Actas urologicas espanolas, vol.37, no.10, pp.619-24, 2013 (SCI-Expanded)
Purpose: We investigated retrospectively the clinical outcomes of the patients with type III inflammatory chronic prostatitis, who were treated with fluoroquinolones with and without an alpha-blocker between 2009-2011.